JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

J Neurol Neurosurg Psychiatry. Published Online First: 9 May 2008. doi:10.1136/jnnp.2007.136457
Copyright © 2008 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text (Rapid PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Cairns, A. G
Right arrow Articles by North, K. N
PubMed
Right arrow Articles by Cairns, A. G
Right arrow Articles by North, K. N

Original articles

Cerebrovascular Dysplasia in Neurofibromatosis Type 1

Anita G Cairns 1* and Kathryn N North 1

1 The Children's Hospital at Westmead, Australia

* To whom correspondence should be addressed. E-mail: anita{at}neetetal.com.

Accepted 8 February 2008


*  Abstract

Objective:To assess the frequency and clinical characteristics of the increasingly recognised complication of cerebrovascular dysplasia in children with Neurofibromatosis type 1 (NF1).

Methods: A series of seven patients with NF1 and cerebrovascular dysplasias that were not secondary to radiotherapy were identified and prospectively assessed. An extensive review of the literature was also performed to identify associated features and the natural history of this potentially severe complication of NF1.

Results:The frequency of cerebrovascular dysplasia in NF1 is 2-5%, and vascular lesions are clearly visible on routine magnetic resonance imaging (MRI) of the brain. The majority of our patients were clinically asymptomatic, despite angiographic progression in some cases. Hypoplastic carotid canals and early appearance on MRI suggest that a proportion of cases of cerebrovascular dysplasia are congenital in origin.

Conclusion:These findings have implications for screening of asymptomatic patients with NF1, and highlight the difficult management decisions in those patients identified with cerebrovascular malformations.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd.